Community- and individual-level correlates of HIV incidence in HPTN 071 (PopART).


Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
08 2023
Historique:
received: 17 12 2022
accepted: 17 08 2023
medline: 31 8 2023
pubmed: 29 8 2023
entrez: 29 8 2023
Statut: ppublish

Résumé

Universal HIV testing and treatment aims to identify all people living with HIV and offer them treatment, decreasing the number of individuals with unsuppressed HIV and thus reducing HIV transmission. Longitudinal follow-up of individuals with and without HIV in a cluster-randomized trial of communities allowed for the examination of community- and individual-level measures of HIV risk and HIV incidence. HPTN 071 (PopART) was a three-arm cluster-randomized trial conducted between 2013 and 2018 that evaluated the use of two combination HIV prevention strategies implemented at the community level to reduce HIV incidence compared to the standard of care. The trial, conducted in 21 communities in Zambia and South Africa, measured HIV incidence over 36 months in a population cohort of ∼2000 randomly selected adults per community aged 18-44. Multilevel models were used to assess the association between HIV incidence and community- and individual-level socio-demographic and behavioural risk factors, as well as prevalence of detectable virus (PDV) defined as the estimated proportion of the community with unsuppressed viral load. Overall HIV incidence was 1.49/100 person-years. Communities with less financial wealth and communities with more individuals reporting having sex partners outside of the community or two or more sexual partners had higher HIV incidence. PDV at 2 years of study was 6.8% and was strongly associated with HIV incidence: for every 50% relative reduction in community PDV, there was a 49% (95% confidence interval [CI]: 37%-58%, p < 0.001) relative decrease in HIV incidence. At the individual level; socio-economic status, AUDIT score, medical male circumcision and certain sexual behaviours were associated with HIV risk. Using data from the PopART randomized trial, we found several associations of HIV incidence with community-level measures reflecting the sexual behaviour and socio-economic make-up of each community. We also found a strong association between community PDV and HIV incidence supporting the use of PDV as a tool for monitoring progress in controlling the epidemic. Lastly, we found significant individual-level factors of HIV risk that are generally consistent with previous HIV epidemiological research. These results have the potential to identify high high-incidence communities, inform structural-level interventions, and optimize individual-level interventions for HIV prevention. ClinicalTrials.gov number, NCT01900977, HPTN 071 [PopArt].

Identifiants

pubmed: 37643290
doi: 10.1002/jia2.26155
pmc: PMC10465013
doi:

Banques de données

ClinicalTrials.gov
['NCT01900977']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26155

Subventions

Organisme : PEPFAR
Pays : United States

Informations de copyright

© 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

Lancet HIV. 2017 Mar;4(3):e122-e133
pubmed: 27989576
PLoS One. 2012;7(12):e53284
pubmed: 23285274
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
AIDS. 2021 Sep 1;35(11):1835-1843
pubmed: 34132219
Lancet Infect Dis. 2014 Apr;14(4):281-90
pubmed: 24602844
Lancet. 2007 Feb 24;369(9562):657-66
pubmed: 17321311
Lancet HIV. 2022 Nov;9(11):e760-e770
pubmed: 36332653
Popul Stud (Camb). 2007 Mar;61(1):73-83
pubmed: 17365874
Science. 2013 Feb 22;339(6122):966-71
pubmed: 23430656
Lancet. 2007 Feb 24;369(9562):643-56
pubmed: 17321310
J Int AIDS Soc. 2020 Feb;23(2):e25452
pubmed: 32072743
Ann Epidemiol. 2018 Jan;28(1):8-12
pubmed: 29153491
Lancet HIV. 2016 Apr;3(4):e183-90
pubmed: 27036994
PLoS One. 2014 Aug 29;9(8):e106230
pubmed: 25171060
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
J Acquir Immune Defic Syndr. 2021 Aug 1;87(Suppl 1):S81-S88
pubmed: 33560041
Epidemics. 2016 Jun;15:56-65
pubmed: 27266849
Afr J AIDS Res. 2013 Nov;12(2):79-84
pubmed: 25871377
N Engl J Med. 2019 Jul 18;381(3):207-218
pubmed: 31314965
Int J Epidemiol. 1997 Feb;26(1):224-7
pubmed: 9126524
JAMA. 2016 Jul 12;316(2):182-90
pubmed: 27404186
AIDS. 2001 Aug;15 Suppl 4:S15-30
pubmed: 11686462
Nature. 2023 Jun;618(7965):575-582
pubmed: 37258664
Sci Transl Med. 2017 Dec 13;9(420):
pubmed: 29237762
PLoS Med. 2005 Nov;2(11):e298
pubmed: 16231970
PLoS One. 2021 Dec 15;16(12):e0260823
pubmed: 34910752
Trials. 2014 Feb 13;15:57
pubmed: 24524229

Auteurs

Timothy Skalland (T)

Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Helen Ayles (H)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Peter Bock (P)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Justin Bwalya (J)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Kwame Shanaube (K)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Nkatya Kasese (N)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Michelle Dupré (M)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Barry Kosloff (B)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Sian Floyd (S)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Ethan Wilson (E)

Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Ayana Moore (A)

FHI 360, Durham, North Carolina, USA.

Susan Eshleman (S)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Sarah Fidler (S)

UK Department of Infectious Disease, Faculty of Medicine, Imperial College NIHR BRC, London, UK.

Richard Hayes (R)

Zambart, Lusaka, Zambia.
London School of Hygiene and Tropical Medicine, London, UK.

Deborah Donnell (D)

Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Fred Hutchinson Cancer Center, Seattle, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH